Displaying drugs 14726 - 14750 of 14958 in total
1,1,1-TRIFLUORO-3-(OCTYLTHIO)ACETONE
Experimental
EVT 201
EVT 201 is a novel partial positive allosteric modulator of the GABAA receptor complex which is being developed as a treatment for insomnia. It is being developed by Evotec Inc.
Investigational
MBO7133
MB07133 is a HepDirect prodrug of an activated form of cytarabine (araC), an anti-cancer drug that is used to treat leukemia but is ineffective against primary liver cancer. AraC's anti-cancer activity is associated with its ability to be converted to its biologically active form, araCTP. However, araC is only slowly...
Investigational
TAK-475
TAK-475 is a "squalene synthase inhibitor", a type of cholesterol-lowering drug that has not yet been brought to market.
Investigational
Flaviolin
Experimental
SLx-4090
SLx-4090 is a microsomal triglyceride transfer protein (MTTP) inhibitor potentially for the treatment of type 2 diabetes.
Investigational
DPI59
Experimental
8-azaxanthine
Experimental
3,5-Diaminophthalhydrazide
Experimental
4-Hydroxy-3-Methyl Butyl Diphosphate
Experimental
Nitrosoethane
Experimental
Methionine Phosphinate
Experimental
Tioxolone
Experimental
Napabucasin
Napabucasin has been investigated for the treatment of Colorectal Carcinoma.
Investigational
6-Hydroxy-5-undecyl-4,7-benzothiazoledione
Experimental
Methyl isocyanate
Methyl isocyanate has been investigated for the treatment of Nosocomial Pneumonia.
Investigational
Pridopidine
Pridopidine has been used in trials studying the treatment of Huntington's Disease.
Investigational
Oxomemazine
Experimental
Zanapezil
Zanapezil (TAK-147) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment.
Investigational
9-Deazahypoxanthine
Experimental
Isatoic anhydride
Experimental
Displaying drugs 14726 - 14750 of 14958 in total